These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33116620)

  • 1. Long Non-Coding RNA NRAD1 and LINC00152 are Highly Expressed and Associated with Prognosis in Patients with Hepatocellular Carcinoma.
    Wang B; Yang S; Zhao W
    Onco Targets Ther; 2020; 13():10409-10416. PubMed ID: 33116620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of long non-coding RNAs DUXAP9 and DUXAP10 is associated with prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Zhu Q; Liu J; Tang J; Guo DL; Li Y; Duan R
    Int J Clin Exp Pathol; 2018; 11(3):1407-1414. PubMed ID: 31938237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
    Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
    Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.
    Dong Y; Yan W; Zhang SL; Zhang MZ; Zhou YP; Ling HH; Ning M; Zhao Y; Huang A; Zhang P
    Oncotarget; 2017 Dec; 8(69):114041-114049. PubMed ID: 29371967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma.
    Yu J; Liu Y; Guo C; Zhang S; Gong Z; Tang Y; Yang L; He Y; Lian Y; Li X; Deng H; Liao Q; Li X; Li Y; Li G; Zeng Z; Xiong W; Yang X
    J Cancer; 2017; 8(4):523-530. PubMed ID: 28367232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ
    Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
    Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
    Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
    Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma.
    Wu Y; Tan C; Weng WW; Deng Y; Zhang QY; Yang XQ; Gan HL; Wang T; Zhang PP; Xu MD; Wang YQ; Wang CF
    Am J Cancer Res; 2016; 6(2):285-99. PubMed ID: 27186403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
    Pan YF; Qin T; Feng L; Yu ZJ
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Jin Y; Zheng X; Wu Y; Fu H
    PLoS One; 2014; 9(7):e101707. PubMed ID: 25025236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.